BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21896329)

  • 1. Inhibitory effect of siRNA complexes with polyamidoamine dendrimer/α-cyclodextrin conjugate (generation 3, G3) on endogenous gene expression.
    Arima H; Tsutsumi T; Yoshimatsu A; Ikeda H; Motoyama K; Higashi T; Hirayama F; Uekama K
    Eur J Pharm Sci; 2011 Oct; 44(3):375-84. PubMed ID: 21896329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
    Hayashi Y; Mori Y; Yamashita S; Motoyama K; Higashi T; Jono H; Ando Y; Arima H
    Mol Pharm; 2012 Jun; 9(6):1645-53. PubMed ID: 22510029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
    Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
    Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
    Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K
    Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo gene delivery mediated by Lactosylated dendrimer/alpha-cyclodextrin conjugates (G2) into hepatocytes.
    Arima H; Yamashita S; Mori Y; Hayashi Y; Motoyama K; Hattori K; Takeuchi T; Jono H; Ando Y; Hirayama F; Uekama K
    J Control Release; 2010 Aug; 146(1):106-17. PubMed ID: 20678990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of polyamidoamine dendrimer conjugate with glucuronylglucosyl-β-cyclodextrin (G3) as a novel carrier for siRNA.
    Abdelwahab AF; Ohyama A; Higashi T; Motoyama K; Khaled KA; Sarhan HA; Hussein AK; Arima H
    J Drug Target; 2014 Dec; 22(10):927-34. PubMed ID: 25148608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Use of Thioalkylated Mannose-Modified Dendrimer (G3)/α-Cyclodextrin Conjugate as an NF-κB siRNA Carrier for the Treatment of Fulminant Hepatitis.
    Motoyama K; Mitsuyasu R; Akao C; Abu Hashim II; Sato N; Tanaka T; Higashi T; Arima H
    Mol Pharm; 2015 Sep; 12(9):3129-36. PubMed ID: 26270769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3).
    Arima H; Chihara Y; Arizono M; Yamashita S; Wada K; Hirayama F; Uekama K
    J Control Release; 2006 Nov; 116(1):64-74. PubMed ID: 17083992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and evaluation of thioalkylated mannose-modified dendrimer (G3)/α-cyclodextrin conjugates as antigen-presenting cell-selective siRNA carriers.
    Motoyama K; Mitsuyasu R; Akao C; Tanaka T; Ohyama A; Sato N; Higashi T; Arima H
    AAPS J; 2014 Nov; 16(6):1298-308. PubMed ID: 25236864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNA.
    Tsutsumi T; Hirayama F; Uekama K; Arima H
    J Pharm Sci; 2008 Aug; 97(8):3022-34. PubMed ID: 17932986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with alpha-cyclodextrin.
    Kihara F; Arima H; Tsutsumi T; Hirayama F; Uekama K
    Bioconjug Chem; 2002; 13(6):1211-9. PubMed ID: 12440855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
    Anno T; Higashi T; Hayashi Y; Motoyama K; Jono H; Ando Y; Arima H
    J Drug Target; 2014 Dec; 22(10):883-90. PubMed ID: 25051178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethylendiamine core PAMAM dendrimers/siRNA complexes as in vitro silencing agents.
    Perez AP; Romero EL; Morilla MJ
    Int J Pharm; 2009 Oct; 380(1-2):189-200. PubMed ID: 19577619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic delivery of transthyretin siRNA mediated by lactosylated dendrimer/α-cyclodextrin conjugates into hepatocyte for familial amyloidotic polyneuropathy therapy.
    Hayashi Y; Mori Y; Higashi T; Motoyama K; Jono H; Sah DW; Ando Y; Arima H
    Amyloid; 2012 Jun; 19 Suppl 1():47-9. PubMed ID: 22519861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors.
    Arima H; Motoyama K; Higashi T
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.
    Hayashi Y; Higashi T; Motoyama K; Mori Y; Jono H; Ando Y; Arima H
    J Drug Target; 2013 May; 21(5):487-96. PubMed ID: 23570609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer.
    Kihara F; Arima H; Tsutsumi T; Hirayama F; Uekama K
    Bioconjug Chem; 2003; 14(2):342-50. PubMed ID: 12643744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates.
    Wada K; Arima H; Tsutsumi T; Chihara Y; Hattori K; Hirayama F; Uekama K
    J Control Release; 2005 May; 104(2):397-413. PubMed ID: 15907588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypseudorotaxanes of pegylated α-cyclodextrin/polyamidoamine dendrimer conjugate with cyclodextrins as a sustained release system for DNA.
    Motoyama K; Hayashida K; Higashi T; Arima H
    Bioorg Med Chem; 2012 Feb; 20(4):1425-33. PubMed ID: 22277591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.